Halozyme Therapeutics Inc
(FRA:RV7)
€
93.44
+0.64 (+0.69%)
Market Cap: 10.74 Bil
Enterprise Value: 12.39 Bil
PE Ratio: 32.16
PB Ratio: 85.56
GF Score: 92/100 Halozyme Therapeutics Inc (FRA:RV7) Transcripts
- 1